WRN Inhibition Leads to its Chromatin-Associated Degradation Via the PIAS4-RNF4-p97/VCP Axis
Fernando Rodríguez-Pérez(Perm State Institute of Arts and Culture), Stephen E. Basham(Therapeutics Clinical Research), Yangzhong Tang, José Ortega, Renee Butler, Charlene Bashore, Huntly M. Morrison, John Filbin, Zhengjian Zhang(Sunesis (United States)), Dean E. Natwick, Daniel J. Anderson, Rafael Miranda(Universidad de Navarra), R. D. Miller, David T. McSwiggen, Lauren Schiff(New York Stem Cell Foundation), Eric Gonzalez, Kylie Cheng, Melina Huey, Jaclyn J. Ho, Mandy Loo, Alec Heckert(Chrono Therapeutics (United States))
Cited by 1
Related Papers
Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction
|Nature Communications|2019|213
Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers
|Clinical Cancer Research|2014|111
Targeted degradation via direct 26S proteasome recruitment
|Nature Chemical Biology|2022|108
Discovery of Potent and Selective RSK Inhibitors as Biological Probes
|Journal of Medicinal Chemistry|2015|84